Clinical Evaluation of Vatha Karappan (Ecezma)
Phase 2
Completed
- Conditions
- Health Condition 1: null- Patients with symptoms ofSkin rashes or bumpy rashes or blisters,Papules, vesicles, pustules,
- Registration Number
- CTRI/2016/06/006983
- Lead Sponsor
- ational institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Inclusion criteria 1. Age 7 to 12 years
2.Skin rashes or bumpy rashes or blisters,
Papules, vesicles, pustules,
Ulcer formation with oozing,
Swelling,
Pain,
Fever
3. Patients willing to give specimen of blood for investigation
when required.
4. Patients willing to be admitted in the hospital or willing to
attend OPD once in 7 days for 14 days
Exclusion Criteria
Scabies
Photo dermatitis
Patient with any other serious illness which needs
discontinuity of trial drug
Seborrhoeic dermatitis
Nummular dermatitis
Fungal or parasitic skin infections
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Good-reduced all clinical symptoms <br/ ><br>Moderate-reduced some clinical symptoms <br/ ><br>Poor-No improvement or change in clinical symptomsTimepoint: With in 14 days
- Secondary Outcome Measures
Name Time Method It is mainly assessed by therapeutic efficacy of the trial drugsTimepoint: 1-3 months <br/ ><br>